The progression of soluble tau protein to neurofibrillary tangles (NFTs) is at the centre of many human neurodegenerative diseases, including Alzheimer's disease (AD) (Spillantini and Goedert, 2013). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.